Maya H Buch (M H Buch, Maya Buch)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 68

Top Topics

Magnetic Resonance

Disease Activity

Rheumatoid Arthritis

Top Venues

Annals of the rheumatic diseases

Nature reviews. Rheumatology

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, Reinhard E Voll, Ferdinand C Breedveld, Josef S Smolen, Jacques-Eric Gottenberg, Xenofon Baraliakos, Hans P Kiener, Daniel Aletaha, John Dudley Isaacs, Maya H Buch, Mary K Crow, Jonathan Kay, Leslie J Crofford, Ronald F Van Vollenhoven, Caroline Ospelt, Stefan Siebert, Margreet Kloppenburg, Iain B McInnes, Thomas Wj Huizinga, Ellen M Gravallese
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023. Annals of the rheumatic diseases 83 (4) (2024)
Christopher P Denton, Enrico De Lorenzis, Elen Roblin, Nina Goldman, Begonya Alcacer-Pitarch, Emma Blamont, Maya H Buch, Maresa Carulli, Caroline Cotton, Francesco Del Galdo, Emma Derrett-Smith, Karen Douglas, Sue Farrington, Kim Fligelstone, Luke Gompels, Bridget Griffiths, Ariane L Herrick, Michael Hughes, Clare E Pain, Georgina Pantano, John D Pauling, Athiveeraramapandian Prabu, Nuala O'Donoghue, Elisabetta A Renzoni, Jeremy Royle, Muditha Samaranayaka, Julia Spierings, Aoife Tynan, Louise Warburton, Voon H Ong
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis. Rheumatology (Oxford, England) (2024)
Maya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, Jon T Giles, Ted Mikuls, Gary G Koch, Steven Ytterberg, Edward Nagy, Hyejin Jo, Kenneth Kwok, Carol A Connell, Karim Richard Masri, Arne Yndestad
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study. RMD open 10 (2) (2024)
Maryam Adas, Mrinalini Dey, Katherine Jones, Heidi Lempp, Maya H Buch, Andrew Cope, James B Galloway, Elena Nikiphorou
What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit. RMD open 10 (3) (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology (2024)
Nkasi Stoll, Mrinalini Dey, Katherine Jones, Maryam Adas, Ailsa Bosworth, Maya H Buch, Andrew Cope, Heidi Lempp, James B Galloway, Elena Nikiphorou
Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study. RMD open 10 (2) (2024)
Maya H Buch, Ziad Mallat, Marc R Dweck, Jason M Tarkin, Declan P O'Regan, Vanessa Ferreira, Taryn Youngstein, Sven Plein
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases. Nature reviews. Rheumatology (2024)
Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, Reinhard E Voll, Ferdinand C Breedveld, Josef S Smolen, Jacques-Eric Gottenberg, Xenofon Baraliakos, Hans P Kiener, Daniel Aletaha, John Dudley Isaacs, Maya H Buch, Mary K Crow, Jonathan Kay, Leslie J Crofford, Ronald F Van Vollenhoven, Caroline Ospelt, Stefan Siebert, Margreet Kloppenburg, Iain B McInnes, Thomas Wj Huizinga, Ellen M Gravallese
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023. Annals of the rheumatic diseases 83 (4) (2024)
Nkasi Stoll, Mrinalini Dey, Katherine Jones, Maryam Adas, Ailsa Bosworth, Maya H Buch, Andrew Cope, Heidi Lempp, James B Galloway, Elena Nikiphorou
Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study. RMD open 10 (2) (2024)
Maya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, Jon T Giles, Ted Mikuls, Gary G Koch, Steven Ytterberg, Edward Nagy, Hyejin Jo, Kenneth Kwok, Carol A Connell, Karim Richard Masri, Arne Yndestad
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study. RMD open 10 (2) (2024)
Christopher P Denton, Enrico De Lorenzis, Elen Roblin, Nina Goldman, Begonya Alcacer-Pitarch, Emma Blamont, Maya H Buch, Maresa Carulli, Caroline Cotton, Francesco Del Galdo, Emma Derrett-Smith, Karen Douglas, Sue Farrington, Kim Fligelstone, Luke Gompels, Bridget Griffiths, Ariane L Herrick, Michael Hughes, Clare E Pain, Georgina Pantano, John D Pauling, Athiveeraramapandian Prabu, Nuala O'Donoghue, Elisabetta A Renzoni, Jeremy Royle, Muditha Samaranayaka, Julia Spierings, Aoife Tynan, Louise Warburton, Voon H Ong
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis-executive summary. Rheumatology (Oxford, England) (2024)
Maryam Adas, Mrinalini Dey, Katherine Jones, Heidi Lempp, Maya H Buch, Andrew Cope, James B Galloway, Elena Nikiphorou
What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit. RMD open 10 (3) (2024)
null null, Peter W Horby, Leon Peto, Natalie Staplin, Mark Campbell, Guilherme Pessoa-Amorim, Marion Mafham, Jonathan R Emberson, Richard Stewart, Benjamin Prudon, Alison Uriel, Christopher A Green, Devesh J Dhasmana, Flora Malein, Jaydip Majumdar, Paul J Collini, Jack Shurmer, Bryan Yates, John Kenneth Baillie, Maya H Buch, Jeremy N Day, Saul N Faust, Thomas F Jaki, Katie Jeffery, Edmund Juszczak, Marian Knight, Wei Shen Lim, Alan Montgomery, Andrew Mumford, Kathryn M Rowan, Guy E Thwaites, Richard Haynes, Martin J Landray
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature communications 15 (1) (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology 20 (2) (2024)
Nkasi Stoll, Mrinalini Dey, Katherine Jones, Maryam Adas, Ailsa Bosworth, Maya H Buch, Andrew Cope, Heidi Lempp, James B Galloway, Elena Nikiphorou
Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study. RMD open 10 (2) (2024)
Nkasi Stoll, Mrinalini Dey, Katherine Jones, Maryam Adas, Ailsa Bosworth, Maya H Buch, Andrew Cope, Heidi Lempp, James B Galloway, Elena Nikiphorou
Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study. RMD open 10 (2) (2024)
null null, Peter W Horby, Leon Peto, Natalie Staplin, Mark Campbell, Guilherme Pessoa-Amorim, Marion Mafham, Jonathan R Emberson, Richard Stewart, Benjamin Prudon, Alison Uriel, Christopher A Green, Devesh J Dhasmana, Flora Malein, Jaydip Majumdar, Paul J Collini, Jack Shurmer, Bryan Yates, John Kenneth Baillie, Maya H Buch, Jeremy N Day, Saul N Faust, Thomas F Jaki, Katie Jeffery, Edmund Juszczak, Marian Knight, Wei Shen Lim, Alan Montgomery, Andrew Mumford, Kathryn M Rowan, Guy E Thwaites, Richard Haynes, Martin J Landray
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature communications 15 (1) (2024)
null null, Peter W Horby, Leon Peto, Natalie Staplin, Mark Campbell, Guilherme Pessoa-Amorim, Marion Mafham, Jonathan R Emberson, Richard Stewart, Benjamin Prudon, Alison Uriel, Christopher A Green, Devesh J Dhasmana, Flora Malein, Jaydip Majumdar, Paul J Collini, Jack Shurmer, Bryan Yates, John Kenneth Baillie, Maya H Buch, Jeremy N Day, Saul N Faust, Thomas F Jaki, Katie Jeffery, Edmund Juszczak, Marian Knight, Wei Shen Lim, Alan Montgomery, Andrew Mumford, Kathryn M Rowan, Guy E Thwaites, Richard Haynes, Martin J Landray
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature communications 15 (1) (2024)
Maya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, Jon T Giles, Ted Mikuls, Gary G Koch, Steven Ytterberg, Edward Nagy, Hyejin Jo, Kenneth Kwok, Carol A Connell, Karim Richard Masri, Arne Yndestad
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study. RMD open 10 (2) (2024)
Laure Gossec, Louis Bessette, Ricardo Machado Xavier, Ennio Giulio Favalli, Andrew Östör, Maya H Buch
Barriers to, Facilitators of, and Interventions to Support Treat-to-Target Implementation in Rheumatoid Arthritis: A Systematic Review. Arthritis care & research (2024)
Maryam Adas, Mrinalini Dey, Katherine Jones, Heidi Lempp, Maya H Buch, Andrew Cope, James B Galloway, Elena Nikiphorou
What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit. RMD open 10 (3) (2024)
Maya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, Jon T Giles, Ted Mikuls, Gary G Koch, Steven Ytterberg, Edward Nagy, Hyejin Jo, Kenneth Kwok, Carol A Connell, Karim Richard Masri, Arne Yndestad
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study. RMD open 10 (2) (2024)
null null, Peter W Horby, Leon Peto, Natalie Staplin, Mark Campbell, Guilherme Pessoa-Amorim, Marion Mafham, Jonathan R Emberson, Richard Stewart, Benjamin Prudon, Alison Uriel, Christopher A Green, Devesh J Dhasmana, Flora Malein, Jaydip Majumdar, Paul J Collini, Jack Shurmer, Bryan Yates, John Kenneth Baillie, Maya H Buch, Jeremy N Day, Saul N Faust, Thomas F Jaki, Katie Jeffery, Edmund Juszczak, Marian Knight, Wei Shen Lim, Alan Montgomery, Andrew Mumford, Kathryn M Rowan, Guy E Thwaites, Richard Haynes, Martin J Landray
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature communications 15 (1) (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology 20 (2) (2024)
Maya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, Jon T Giles, Ted Mikuls, Gary G Koch, Steven Ytterberg, Edward Nagy, Hyejin Jo, Kenneth Kwok, Carol A Connell, Karim Richard Masri, Arne Yndestad
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study. RMD open 10 (2) (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology 20 (2) (2024)
null null, Peter W Horby, Leon Peto, Natalie Staplin, Mark Campbell, Guilherme Pessoa-Amorim, Marion Mafham, Jonathan R Emberson, Richard Stewart, Benjamin Prudon, Alison Uriel, Christopher A Green, Devesh J Dhasmana, Flora Malein, Jaydip Majumdar, Paul J Collini, Jack Shurmer, Bryan Yates, John Kenneth Baillie, Maya H Buch, Jeremy N Day, Saul N Faust, Thomas F Jaki, Katie Jeffery, Edmund Juszczak, Marian Knight, Wei Shen Lim, Alan Montgomery, Andrew Mumford, Kathryn M Rowan, Guy E Thwaites, Richard Haynes, Martin J Landray
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature communications 15 (1) (2024)
Nkasi Stoll, Mrinalini Dey, Katherine Jones, Maryam Adas, Ailsa Bosworth, Maya H Buch, Andrew Cope, Heidi Lempp, James B Galloway, Elena Nikiphorou
Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study. RMD open 10 (2) (2024)
Raluca B Dumitru, Lesley-Anne Bissell, Bara Erhayiem, Graham Fent, Ananth Kidambi, Giuseppina Abignano, John P Greenwood, John D Biglands, Francesco Del Galdo, Sven Plein, Maya H Buch
Subclinical Systemic Sclerosis Primary Heart Involvement by Cardiovascular Magnetic Resonance Shows No Significant Interval Change. ACR open rheumatology 5 (2) (2023)
Raluca B Dumitru, Lesley-Anne Bissell, Bara Erhayiem, Graham Fent, Ananth Kidambi, Giuseppina Abignano, John P Greenwood, John D Biglands, Francesco Del Galdo, Sven Plein, Maya H Buch
Subclinical Systemic Sclerosis Primary Heart Involvement by Cardiovascular Magnetic Resonance Shows No Significant Interval Change. ACR open rheumatology (2023)
Christopher P Denton, Enrico De Lorenzis, Elen Roblin, Nina Goldman, Begonya Alcacer-Pitarch, Emma Blamont, Maya H Buch, Maresa Carulli, Caroline Cotton, Francesco Del Galdo, Emma Derrett-Smith, Karen Douglas, Sue Farrington, Kim Fligelstone, Luke Gompels, Bridget Griffiths, Ariane L Herrick, Michael Hughes, Clare E Pain, Georgina Pantano, John D Pauling, Athiveeraramapandian Prabu, Nuala O'Donoghue, Elisabetta Renzoni, Jeremy Royle, Muditha Samaranayaka, Julia Spierings, Aoife Tynan, Louise Warburton, Voon H Ong
Management of systemic sclerosis: British Society for Rheumatology guideline scope. Rheumatology advances in practice 7 (1) (2023)
Raluca B Dumitru, Lesley-Anne Bissell, Bara Erhayiem, Graham Fent, Ananth Kidambi, Giuseppina Abignano, John P Greenwood, John D Biglands, Francesco Del Galdo, Sven Plein, Maya H Buch
Subclinical Systemic Sclerosis Primary Heart Involvement by Cardiovascular Magnetic Resonance Shows No Significant Interval Change. ACR open rheumatology 5 (2) (2023)
Maxime Dougados, Christina Charles-Schoeman, Zoltán Szekanecz, Jon T Giles, Steven R Ytterberg, Deepak L Bhatt, Gary G Koch, Ivana Vranic, Joseph Wu, Cunshan Wang, Kenneth Kwok, Sujatha Menon, Carol A Connell, Arne Yndestad, Jose L Rivas, Maya H Buch
Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme. Annals of the rheumatic diseases (2023)
Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, Reinhard E Voll, Ferdinand C Breedveld, Josef S Smolen, Jacques-Eric Gottenberg, Xenofon Baraliakos, Hans P Kiener, Daniel Aletaha, John Dudley Isaacs, Maya H Buch, Mary K Crow, Jonathan Kay, Leslie J Crofford, Ronald F Van Vollenhoven, Caroline Ospelt, Stefan Siebert, Margreet Kloppenburg, Iain B McInnes, Thomas Wj Huizinga, Ellen M Gravallese
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023. Annals of the rheumatic diseases (2023)
Christina Charles-Schoeman, Maya H Buch, Maxime Dougados, Deepak L Bhatt, Jon T Giles, Steven R Ytterberg, Gary G Koch, Ivana Vranic, Joseph Wu, Cunshan Wang, Kenneth Kwok, Sujatha Menon, Jose L Rivas, Arne Yndestad, Carol A Connell, Zoltán Szekanecz
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance. Annals of the rheumatic diseases (2022)
Alessia Alunno, Felice Rivellese, Kim Lauper, Daniel Aletaha, Maya H Buch, Laure Gossec, Peter Mandl, Pedro M Machado, Caroline Ospelt, Anna Moltó, Sofia Ramiro, Elena Nikiphorou, Alexandre Sepriano
EMerging EULAR NETwork (EMEUNET): a remarkable foundation for the future. RMD open 7 (3) (2022)
Bernard G Combe, Robin Besuyen, Antonio Gómez-Centeno, Tsukasa Matsubara, Juan José Sancho Jimenez, Zhaoyu Yin, Maya H Buch
Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis. Rheumatology and therapy (2022)
Alexis Dechosal, Robert David Sandler, François Zimmermann, David Roofeh, Michael Hughes, John D Pauling, Susan L Murphy, Yen Tzu Chen, Whitney Townsend, Maya H Buch, Dinesh Khanna
Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: an international collaborative scoping review. Rheumatology (Oxford, England) 61 (8) (2022)
John Fitton, Andrew Melville, Kamran Naraghi, Jacqueline Nam, Shouvik Dass, Paul Emery, Maya H Buch
Single-centre experience of refractory rheumatoid arthritis. Rheumatology advances in practice 6 (2) (2022)
Yvonne Tan, Maya H Buch
'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps. RMD open 8 (2) (2022)
Josef S Smolen, Robert B M Landewe, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher John Edwards, Kimmie L Hyrich, Janet E Pope, Savia de Souza, Tanja Alexandra Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin L Winthrop, Alejandro Balsa, Joan M Bathon, Maya H Buch, Gerd-Rüdiger R Burmester, Frank Buttgereit, Mario Humberto Cardiel, Katerina Chatzidionysiou, Catalin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques-Eric Gottenberg, Espen A Haavardsholm, AnnaMaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B McInnes, Eduardo F Mysler, Peter Nash, Gyula Poor, Gorica G Ristic, Felice Rivellese, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Nikolay Stoilov, Anja Strangfeld, Annette van der Helm-van Mil, Elsa van Duuren, Thea P M Vliet Vlieland, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the rheumatic diseases (2022)
Martin J Bergman, Maya H Buch, Yoshiya Tanaka, Gustavo Citera, Sami Bahlas, Ernest Wong, Yanna Song, Patrick Zueger, Mira Ali, Vibeke Strand
Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials. Rheumatology and therapy 9 (6) (2022)
Maya H Buch, Walter P Maksymowych, Maarten Boers
Managing the selection of placebo group switched to experimental treatment group in post-randomised controlled trial extension studies. Annals of the rheumatic diseases 81 (5) (2022)
John D Biglands, Bara Erhayiem, Graham Fent, John P Greenwood, Raluca B Dumitru, Jacqueline Andrews, Paul Emery, Maya H Buch, Sven Plein
No differences in myocardial perfusion between treatment-naive, early rheumatoid arthritis patients and healthy controls. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Tore K Kvien, Alejandro Balsa, Neil Betteridge, Maya H Buch, Patrick Durez, Ennio Giulio Favalli, Guillaume Favier, Cem Gabay, Rinie Geenen, Ioanna Gouni-Berthold, Frank van den Hoogen, Alison Kent, Lars Klareskog, Mikkel Ostergaard, Karel Pavelka, Joaquim Polido Pereira, Anne Grete Semb, Magnus Sköld, Maxime Dougados
Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities. RMD open 6 (2) (2021)
Daniel Aletaha, René Westhovens, Cecile Gaujoux-Viala, Giovanni Adami, Alan Matsumoto, Paul Bird, Osvaldo Daniel Messina, Maya H Buch, Beatrix Bartok, Zhaoyu Yin, Ying Guo, Thijs Hendrikx, Gerd-Rüdiger R Burmester
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3. RMD open 7 (2) (2021)
Raluca Dumitru, Alex Goodall, David Broadbent, Francesco Del Galdo, Ai Lyn Tan, John Biglands, Maya H Buch
First pilot study of extracellular volume MRI measurement in peripheral muscle of systemic sclerosis patients suggests diffuse fibrosis. Rheumatology (Oxford, England) (2021)
Rudresh Shukla, Paul Emery, Maya H Buch
Efficacy of tumour-necrosis factor-inhibitor in moderate disease activity rheumatoid arthritis: sub-analysis of the 'VEDERA' trial. Rheumatology (Oxford, England) (2021)
Samantha S R Crossfield, Maya H Buch, Paul D Baxter, Sarah R Kingsbury, Mar Pujades Rodriguez, Philip Gerard Conaghan
Changes in the pharmacological management of rheumatoid arthritis over two decades. Rheumatology (Oxford, England) 60 (9) (2021)
Sven Plein, Maya H Buch
Response to: 'Correspondence on 'Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naive, early rheumatoid arthritis'' by Georgiadis et al. Annals of the rheumatic diseases (2021)
James Galloway, Kevin Barrett, Peter Irving, Kaivan Khavandi, Monica Nijher, Ruth Nicholson, Simon de Lusignan, Maya H Buch
Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study. RMD open 6 (3) (2021)
Mark Kacar, John Fitton, Andrew K Gough, Maya H Buch, Dennis G McGonagle, Sinisa Savic
Mixed results with baricitinib in biological-resistant adult-onset Still's disease and undifferentiated systemic autoinflammatory disease. RMD open 6 (2) (2021)
Alexis Dechosal, David Roofeh, Whitney Townsend, Michael Hughes, Robert D Sandler, François Zimmermann, John D Pauling, Maya H Buch, Zsuzsanna H McMahan
Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: a scoping review protocol. BMJ open 11 (3) (2021)
Raluca B Dumitru, Lesley-Anne Bissell, Bara Erhayiem, Ananth Kidambi, Ana-Maria H Dumitru, Graham Fent, Giuseppina Abignano, Helena Donica, Agata Burska, John P Greenwood, John Biglands, Dominik Schlosshan, Francesco Del Galdo, Sven Plein, Maya H Buch
Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers. RMD open 7 (3) (2021)
György Nagy, Nadia M T Roodenrijs, Paco Mj Welsing, Melinda Kedves, Attila Hamar, Marlies C van der Goes, Alison Kent, Margot Bakkers, Etienne Blaas, Ladislav Senolt, Zoltán Szekanecz, Ernest Choy, Maxime Dougados, Johannes W G Jacobs, Rinie Geenen, Hans Wj Bijlsma, Angela Zink, Daniel Aletaha, Leonard Schoneveld, Piet van Riel, Loriane Gutermann, Yeliz Prior, Elena Nikiphorou, Gianfranco Ferraccioli, Larissa Valor-Méndez, Kimme L Hyrich, Ulf Mueller-Ladner, Maya H Buch, Iain B McInnes, Désirée Mfm van der Heijde, Jacob M van Laar
EULAR definition of difficult-to-treat rheumatoid arthritis. Annals of the rheumatic diseases 80 (1) (2020)
Josef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B McInnes, Alexandre Sepriano, Ronald F van Vollenhoven, Maarten P T de Wit, Daniel Aletaha, Martin Aringer, John Askling, Alejandro Balsa, Maarten Boers, Alfons A den Broeder, Maya H Buch, Frank Buttgereit, Roberto Caporali, Mario Humberto Cardiel, Diederik De Cock, Catalin Codreanu, Maurizio Cutolo, Christopher John Edwards, Yvonne van Eijk-Hustings, Paul Emery, Axel Finckh, Laure Gossec, Jacques-Eric Gottenberg, Merete Lund Hetland, Thomas Wj Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller-Ladner, Eduardo F Mysler, José António Pereira Da Silva, Gyula Poór, Janet E Pope, Andrea Rubbert-Roth, Adeline Ruyssen-Witrand, Kenneth G Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the rheumatic diseases 79 (6) (2020)
Sophie I Mavrogeni, Maya H Buch, George Markousis-Mavrogenis, Raluca Bianca Dumitru, Nicola Riccardo Pugliese, Luna Gargani
The perpetual sword of Damocles: Cardiac involvement in systemic sclerosis and the role of non-invasive imaging modalities in medical decision making. European journal of rheumatology 7 (Suppl 3) (2020)
Costantino Pitzalis, Ernest H S Choy, Maya H Buch
Transforming clinical trials in rheumatology: towards patient-centric precision medicine. Nature reviews. Rheumatology 16 (10) (2020)
Maya H Buch, Stephen Eyre, Dennis McGonagle
Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis. Nature reviews. Rheumatology 17 (1) (2020)
Sven Plein, Bara Erhayiem, Graham Fent, Sarah Horton, Raluca Bianca Dumitru, Jacqueline Andrews, John P Greenwood, Paul Emery, Elizabeth Ma Hensor, Paul Baxter, Sue Pavitt, Maya H Buch
Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis. Annals of the rheumatic diseases 79 (11) (2020)
Paul Emery, Sarah Horton, Raluca Bianca Dumitru, Kamran Naraghi, Désirée Mfm van der Heijde, Richard J Wakefield, Elizabeth M A Hensor, Maya H Buch
Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial. Annals of the rheumatic diseases 79 (4) (2020)
Md Yuzaiful Md Yusof, Edward M Vital, Damien M McElvenny, Elizabeth M A Hensor, Sudipto Das, Shouvik Dass, Andy C Rawstron, Maya H Buch, Paul Emery, Sinisa Savic
Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases. Arthritis & rheumatology (Hoboken, N.J.) 71 (11) (2019)
Maya H Buch, Andrew R Melville, Dennis G McGonagle
'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients'. Annals of the rheumatic diseases 79 (11) (2019)
Graham Fent, Kulveer Mankia, Bara Erhayiem, Laura Hunt, Jacqueline Leong Nam, Lesley-Anne Bissell, James Rj Foley, Pei G Chew, Louise E Brown, John P Greenwood, Paul Emery, Sven Plein, Maya H Buch
First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis. Annals of the rheumatic diseases 78 (8) (2019)
Marco Matucci-Cerinic, Yannick Allanore, Arthur Kavanaugh, Maya H Buch, Hendrik Schulze-Koops, Eugeniusz J Kucharz, Heike Woehling, Goran Babic, Johann Poetzl, Adanna Davis, Arnd Schwebig
Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study. RMD open 4 (2) (2018)
Søren Andreas Just, Frances Humby, Hanne Lindegaard, Laurent Meric de Bellefon, Patrick Durez, Elsa Vieira-Sousa, Rui Teixeira, Maria Stoenoiu, Jens Werlinrud, Sofie Rosmark, Pia Veldt Larsen, Arthur Pratt, Ernest Choy, Nagui Gendi, Maya H Buch, Christopher J Edwards, Peter C Taylor, Iain B McInnes, João Eurico Fonseca, Costantino Pitzalis, Andrew Filer
Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe. RMD open 4 (2) (2018)
L Ouboussad, L Hunt, E M A Hensor, J L Nam, N A Barnes, P Emery, M F McDermott, Maya H Buch
Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis. Arthritis research & therapy 19 (1) (2017)